These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35237508)

  • 21. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.
    Zhao Q; Hu G; Xiao W; Chen Y; Shen M; Tang Q; Ning X
    Medicine (Baltimore); 2017 Sep; 96(35):e7920. PubMed ID: 28858114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
    Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
    [No Abstract]   [Full Text] [Related]  

  • 23. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
    Cassidy RJ; Switchenko JM; Cheng E; Jiang R; Jhaveri J; Patel KR; Tanenbaum DG; Russell MC; Steuer CE; Gillespie TW; McDonald MW; Landry JC
    Cancer; 2017 Nov; 123(22):4325-4336. PubMed ID: 28759121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
    Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
    Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.
    Cushman TR; Shaaban SG; Moreno AC; Lin C; Verma V
    Am J Clin Oncol; 2019 Feb; 42(2):154-159. PubMed ID: 30499838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
    Sher DJ; Yan J; Day A; Sumer BD; Pham NL; Khan S; Zhu H
    Oral Oncol; 2019 Jan; 88():18-26. PubMed ID: 30616791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
    Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
    Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.
    Spiotto MT; Jefferson G; Wenig B; Markiewicz M; Weichselbaum RR; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):691-699. PubMed ID: 28426848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
    Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
    Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction Chemotherapy for Locally Advanced Esophageal Cancer.
    Harada G; Bonadio RRDCC; de Araújo FCC; Victor CR; Sallum RAA; Junior UR; Cecconello I; Takeda FR; de Castria TB
    J Gastrointest Cancer; 2020 Jun; 51(2):498-505. PubMed ID: 31240598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer.
    de Vos-Geelen J; Hoebers FJP; Geurts SME; Hoeben A; de Greef BTA; Voncken FEM; Bogers JHA; Braam PM; Muijs CKT; de Jong MA; Kasperts N; Rozema T; Jeene PM; Blom GJ; van Dieren JM; Hulshof MCCM; van Laarhoven HWM; Grabsch HI; Lemmens VEPP; Tjan-Heijnen VCG; Nieuwenhuijzen GAP
    Acta Oncol; 2020 Aug; 59(8):895-903. PubMed ID: 32319845
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of the efficacy of definitive chemoradiation therapy and surgery followed by adjuvant radiation therapy in advanced-stage oral tongue cancer.
    Kravets OV; Protsyk VS; Burtyn OV; Hurianov VG
    Exp Oncol; 2020 Sep; 42(3):228-232. PubMed ID: 32996744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
    Goense L; van Rossum PSN; Xi M; Maru DM; Carter BW; Meijer GJ; Ho L; van Hillegersberg R; Hofstetter WL; Lin SH
    Ann Surg Oncol; 2018 Jun; 25(6):1598-1607. PubMed ID: 29569125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
    Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
    Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
    Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
    Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.